PMID: 19027440
Question: Can we predict which head and neck cancer survivors develop fears of recurrence?
Correct Answer: yes

======================= Launch the MCC process =======================
PMID: 19027440
Question: Can we predict which head and neck cancer survivors develop fears of recurrence?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**

The core question is whether it's possible to predict which survivors of head and neck cancer (HNC) will develop fears of cancer recurrence. Key information to identify in the abstract includes:

- Identification of potential predictors of fear of recurrence.
- The strength and nature of these predictors.
- The study design and robustness of the findings.
- Relevance of the predictors to the initial question.

**2. Evidence Evaluation**

The study employed a prospective repeat measures design with 82 HNC patients, assessing fears of recurrence both before and after treatment. Key findings include:

- A third of patients reported high levels of fear of recurrence at diagnosis, with 12% maintaining similar levels 6-8 months post-treatment.
- Fears of recurrence were not associated with socio-demographic factors or disease/treatment-related variables.
- Path analyses revealed that pre-treatment fears and optimism directly predicted post-treatment fears of recurrence.
- Optimism emerged as the strongest predictor, independent of anxiety and initial fear levels.

The methodology appears robust with a clear longitudinal approach, and the use of path analysis strengthens the reliability of the identified predictors. The focus on psychological factors like optimism directly addresses the potential for prediction.

**3. Conclusion**

Based on the study's findings, there are identifiable predictors (pre-treatment fears and optimism) that can help predict which HNC survivors may develop fears of recurrence. The evidence is scientifically sound and directly relevant to the question posed.

**4. Final Answer**

**My final choice is: "yes"**
GPT selected: yes

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether we can predict which head and neck cancer (HNC) survivors will develop fears of recurrence. The key is determining whether the study identifies specific factors that reliably predict long-term fears of recurrence in survivors.  

**2. Evidence Evaluation**  
The abstract states that path analyses demonstrated fears of recurrence *after treatment* were directly predicted by **pre-treatment fears** and **optimism**. Specifically, optimism was the strongest predictor, independent of anxiety and baseline fear levels. Importantly, the study found that fears of recurrence were **not** associated with socio-demographic factors, disease/treatment characteristics, or symptoms. Thus, the study identifies pre-treatment fears and optimism as significant predictors.  

**3. Conclusion**  
The study provides clear evidence that pre-treatment fears of recurrence and optimism are predictive of long-term fears. Since these factors can be measured at baseline, the answer is "yes"â€”the study supports the possibility of predicting which survivors will develop persistent fears of recurrence using these variables.  

**4. Final Answer:**  
**My final choice is: "yes"**
Qwen selected: yes

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether predictors exist for fear of recurrence (FoR) in head and neck cancer (HNC) survivors. Key information to identify includes: (1) factors associated with FoR (e.g., socio-demographic, disease-related, psychological), (2) longitudinal predictors of FoR, and (3) the role of optimism and pre-treatment fears.

**2. Evidence Evaluation**  
- The study found no association between FoR and socio-demographic, disease, treatment, or symptom-related factors.  
- Pre-treatment FoR and optimism directly predicted long-term FoR after treatment, independent of anxiety and depression.  
- Optimism was identified as the strongest predictor, even when accounting for components of the Common Sense Model (CSM).  
- The sample size (n=82) and prospective design support reliability, though limited generalizability due to small size.  

**3. Conclusion**  
The evidence confirms that pre-treatment FoR and optimism are significant predictors of long-term FoR. Since these factors enable prediction, the answer is "yes."  

**4. Final Answer**  
**My final choice is: "yes"**
DeepSeek selected: yes

Initial consensus: All models selected yes